1. Home
  2. Live Updates
  3. Division of surgery

Live Breaking News & Updates on Division of surgery

Stay informed with the latest breaking news from Division of surgery on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Division of surgery and stay connected to the pulse of your community

First Safety and Efficacy Data of Rakuten Medical's Alluminox Treatment using ASP-1929 in Combination with anti-PD-1 for Recurrent and/or Metastatic Head and Neck Cancer Presented at AHNS 2023

/PRNewswire/ -- Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell targeting therapies based on its...

Switzerland , Taiwan , United-states , India , Japan , Texas , Netherlands , Japanese , American , Annm-gillenwater , Hisataka-kobayashi , Mickey-mikitani

Dual immunotherapy promising for treatment of recurrent or metastatic nasopharyngeal cancer

Singapore: The dual immunotherapy, PD-1 immune checkpoint inhibitor nivolumab and CTLA-4 targeting drug ipilimumab effectively treat recurrent or metastatic nasopharyngeal carcinoma (NPC), a recent...

China , Singapore , Chinese , Gopal-iyer , National-taiwan-university , Nature-communications , Institute-of-molecular , Division-of-surgery , Genome-institute-of-singapore , National-cancer-centre-singapore , Department-of-lung , Division-of-medical-oncology

PSMA-Targeted Imaging Agent Posluma Approved to Aid in Prostate Cancer Detection

Posluma, a radiohybrid PSMA-targeted PET imaging agent for prostate cancer, has received FDA approval.

Texas , United-states , Brianf-chapin , Drug-administration , University-of-texas-md-anderson-cancer-center , Department-of-urology , Division-of-surgery , Associate-professor , Cancer-center , Coordinating-investigator ,

PSMA-Targeted Imaging Agent Posluma Approved to Aid in Prostate Cancer Detection

Posluma, a radiohybrid PSMA-targeted PET imaging agent for prostate cancer, has received FDA approval.

Texas , United-states , Brianf-chapin , Department-of-urology , University-of-texas-md-anderson-cancer-center , Division-of-surgery , Drug-administration , Associate-professor , Cancer-center , Coordinating-investigator ,

U.S. FDA Approves Blue Earth Diagnostics' POSLUMA (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

POSLUMA will be commercially available in the United States in early June 2023 

Munich , Bayern , Germany , United-states , Texas , Scintomics-gmb , Davidm-schuster , Shelby-moneer , Davide-gauden , Brianf-chapin , Winship-cancer-institute-of-emory-university , Emory-university-school-of-medicine

FDA Approves Imaging Agent With Radiohybrid Technology to Identify Location, Extent of Prostate Cancer

The radiohybrid imaging agent allowed positron emission tomography to identify prostate cancer with an 83% detection rate.

United-states , Texas , Brianf-chapin , Davidm-schuster , Davide-gauden , Division-of-surgery , Department-of-urology , University-of-texas-md-anderson-cancer-center , Winship-cancer-institute-at-emory-university , Emory-university-school-of-medicine , Blue-earth-diagnostics

U.S. FDA Approves Blue Earth Diagnostics' POSLUMA (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

- POSLUMA will be commercially available in the United States in early June 2023 - Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative

Germany , Milan , Lombardia , Italy , United-kingdom , Texas , United-states , Munich , Bayern , Clare-gidley , Mike-beyer , Priscilla-harlan

Rakuten Medical to Present New Data of Alluminox™ Treatment using ASP-1929 in Combination with anti-PD-1 at AHNS 2023

/PRNewswire/ -- Rakuten Medical, Inc. (Rakuten Medical), a global biotechnology company developing and commercializing precision, cell-targeting therapies...

Japan , United-states , Montreal , Quebec , Canada , Netherlands , India , Taiwan , Texas , Switzerland , American , Japanese

Rakuten Medical to Present New Data of Alluminox™ Treatment using ASP-1929 in Combination with anti-PD-1 at AHNS 2023

Rakuten Medical to Present New Data of Alluminox™ Treatment using ASP-1929 in Combination with anti-PD-1 at AHNS 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Japan , Netherlands , Montreal , Quebec , Canada , United-states , India , Switzerland , Texas , Taiwan , Japanese , American

New study shows for the first time how cancer evades the immune system

The findings could help in the search for novel ways of treating even the most lethal of cancers. Read more at straitstimes.com.

Singapore , Gopal-iyer , Department-of-head , University-of-southampton , Alan-turing-institute , Division-of-surgery , Researcha-star-singapore-immunology-network , Agency-for-science , Nature-communications-on , National-cancer-centre-singapore , Singapore-immunology-network , Nature-communications